Medicinal Products
Reseligo 10,8 mg implantat u napunjenoj štrcaljki
| Name |
Reseligo 10,8 mg implantat u napunjenoj štrcaljki |
| Marketing Authorisation Number |
HR-H-863040656 |
| Active Substance |
goserelinacetat |
| Composition |
jedan implantat sadrži 10,8 mg goserelina (u obliku goserelinacetata) |
| Pharmaceutical Form |
Implantat u napunjenoj štrcaljki |
| Manufacturer |
AMW GmbH Arzneimittelwerk Warngau, Warngau, Njemačka |
| Marketing Authorisation Holder |
Zentiva k.s., U Kabelovny 130, Dolni Mecholupy, Prag 10, Češka |
| Marketing Authorisation Date |
28.02.2023 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/20-02/02 |
| Registration Number |
381-12-01/70-23-40 |
| Prescription |
na recept |
| Type of prescription |
ograničeni recept
|
| Distribution |
u ljekarni |
| Advertising to general public |
zabranjeno |
| ATC Code |
L02AE03 |
| Medicinal product marketed in the Croatia |
Da |
| SmPC |
download |
| PL |
download |
| Public Assessment Report |
download
|
Packaging
| Packaging description |
MA Number for Packaging |
Marketing status |
Shortage status |
| 1 vrećica s implantatom u napunjenoj štrcaljki, u kutiji |
HR-H-863040656-01 |
- |
- |
| 3 vrećice s implantatom u napunjenoj štrcaljki, u kutiji |
HR-H-863040656-02 |
- |
- |
Direct Healthcare Professional Communication
| Name |
Date |
Download |
| Pismo zdravstvenim radnicima o pravilnoj primjeni lijekova Reseligo 3,6 mg i 10,8 mg implantat u napunjenoj štrcaljki (goserelin) |
30.08.2016 |
Alvogen d.o.o. |
Back
